Skip to main content

Global Healthcare Logistics Market to grow at 8% CAGR due to demand for faster drug access by 2030

 


The global healthcare logistics market is projected to grow at a CAGR of 8% from 2025 to 2030, driven by the rising demand for time-sensitive and temperature-controlled logistics solutions, the increasing complexity of global healthcare supply chains, and technological advancements in automation and tracking systems. 

Healthcare logistics encompasses services such as freight forwarding, warehousing, cold chain solutions, and last-mile delivery tailored to the unique needs of healthcare products like pharmaceuticals, vaccines, and medical devices. The market's growth is supported by advancements in digital logistics platforms, increasing regulatory compliance requirements, and the growing role of third-party logistic (3PL) providers in the healthcare sector.

Download a free sample report now 👉
https://meditechinsights.com/healthcare-logistics-market/request-sample/

Rising demand for cold chain logistics and real-time tracking driving market growth

The increasing demand for biologics and temperature-sensitive pharmaceuticals has significantly boosted the demand for cold chain logistics. Cold chain solutions are critical for maintaining product stability and efficacy, particularly for vaccines, biologics, and specialty drugs. Additionally, the integration of real-time tracking technologies is enabling enhanced visibility and quality assurance across the supply chain. The demand for time-definite services, such as Time Definite International (TDI), is growing in tandem with the rise in urgent delivery requirements for diagnostics, transplant materials, and life-saving drugs. Moreover, healthcare logistics is playing a pivotal role in clinical trials by ensuring the seamless transport of investigational drugs, lab kits, and patient samples under stringent regulatory guidelines. This demand is further driven by the rise in home healthcare services and the need for last-mile delivery of medications and medical supplies.

Technological advancements to boost demand for healthcare logistics services

Technological progress has been a key enabler of growth in the healthcare logistics market. Innovations such as IoT-enabled cold chain solutions, automated warehousing, and blockchain for supply chain transparency are transforming the industry. AI-powered logistics platforms are optimizing route planning, inventory management, and predictive analytics, enhancing operational efficiency and cost-effectiveness. Additionally, drone deliveries and robotics are emerging as potential game changers in last-mile logistics, particularly for remote or underserved areas. These advancements are driving the adoption of technology-driven solutions for reliable and efficient healthcare logistics services.

Competitive Landscape Analysis

The healthcare logistics market is highly competitive, with major players such as DHL Supply Chain, FedEx Healthcare, UPS Healthcare, DB Schenker, Kuehne + Nagel, CEVA Logistics (part of CMA CGM Group), and SF Express leading the industry. These companies are focusing on expanding their global network, adopting advanced technologies, and forming strategic collaborations to enhance their service offerings.    

Download a sample report for in-depth competitive insights
https://meditechinsights.com/healthcare-logistics-market/request-sample/

Market Segmentation

This report by Medi-Tech Insights provides the size of the global healthcare logistics market at the regional- and country-level from 2023 to 2030. The report further segments the market based on application and service type.

  • Market Size & Forecast (2023-2030), By Application, USD Billion
    • Pharmaceuticals
    • Medical Devices
    • Clinical Trials
    • Others
  • Market Size & Forecast (2023-2030), By Service Type, USD Billion
    • Cold Chain
    • Freight Forwarding
    • Warehousing
    • Last-Mile Delivery
    • Clinical Trial Logistics
    • Others
  • Market Size & Forecast (2023-2030), By Region, USD Billion
    • North America
      • US
      • Canada
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more